ST Tiansheng (002872.SZ) issued an announcement. The company recently received approval from the State Drug Administration...
According to the Zhitong Finance App, ST Tiansheng (002872.SZ) issued an announcement. The company recently received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration for “acetaminophen tablets”. The drug has passed the consistency evaluation of the quality and efficacy of the generic drug.
Acetaminophen tablets are acetanilide-based antipyretic analgesics. They are mainly suitable for fevers caused by the common cold or influenza. They are also used to relieve mild to moderate pain such as headache, arthralgia, migraine, toothache, muscle pain, neuralgia, and dysmenorrhea. Acetaminophen tablets belong to the “National Catalogue of Essential Medicines (2018)” and category A of the “National Catalogue of Drugs for Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance (2020)”.